This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Clean Air and Lung Health
January 29, 2019
ERS Vision: Take the Active Option for your Health
January 29, 2019
Push-ups for Aspergillosis Research
January 29, 2019
What is Aspergillosis? – Fungal Infections & Symptoms
January 29, 2019
Aspergillosis & antibody testing
January 29, 2019
Patients Meeting – Rome 2010
January 29, 2019
Some health effects of mould exposure
January 29, 2019
Interview with CPA patient RW on long term antifungal treatments
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video